Inspiration Healthcare Group (LSE:IHC) ROCE % : 0.79% (As of Jul. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Inspiration Healthcare Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Inspiration Healthcare Group's annualized ROCE % for the quarter that ended in Jul. 2023 was 0.79%.

Inspiration Healthcare Group ROCE % Historical Data

The historical data trend for Inspiration Healthcare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspiration Healthcare Group ROCE % Chart

Inspiration Healthcare Group Annual Data

Trend

Dec14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

ROCE %

Get a 7-Day Free Trial

24.27

13.05

13.97

11.08

1.07

Inspiration Healthcare Group Semi-Annual Data
	Dec13	Jun14	Dec14	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
ROCE %	Get a 7-Day Free Trial															14.43	8.35	4.95	-2.66	0.79

Inspiration Healthcare Group ROCE % Calculation

Inspiration Healthcare Group's annualized ROCE % for the fiscal year that ended in Jan. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	0.471	/	( ( (50.108 - 7.723)	+	(54.894 - 9.244) )	/ 2 )
	=	0.471	/	( (42.385	+	45.65)	/ 2 )
	=	0.471	/	44.0175
	=	1.07 %

Inspiration Healthcare Group's ROCE % of for the quarter that ended in Jul. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jul. 2023 )		(Q: Jan. 2023 )		(Q: Jul. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jul. 2023 )		(Q: Jan. 2023 )		(Q: Jul. 2023 )
	=	0.36	/	( ( (54.894 - 9.244)	+	(53.147 - 8.068) )	/ 2 )
	=	0.36	/	( ( 45.65	+	45.079 )	/ 2 )
	=	0.36	/	45.3645
	=	0.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Jul. 2023) EBIT data.

Inspiration Healthcare Group (LSE:IHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Inspiration Healthcare Group ROCE % Related Terms

Thank you for viewing the detailed overview of Inspiration Healthcare Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspiration Healthcare Group (LSE:IHC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspiration Healthcare Group PLC (LSE:IHC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 7/8 Commerce Park, Commerce Way, Croydon, GBR, CR0 4YL

Website

https://www.inspirationhealthcaregroup.com

Inspiration Healthcare Group PLC supplies outcome-improving medical devices in the areas of neonatal intensive care and patient warming. It operates in the Critical Care Medical Devices segment which includes Critical Care, Operating Theatre, and Home Healthcare. The company derives the maximum of its revenue from the United Kingdom through the Critical Care market division.